LASAPharmaceuticals
Lassonde Industries Inc — Profit & Loss Statement
₹5.67
-12.87%
Lassonde Industries Inc Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Diluted EPS | -2.95 | -4.34 | -7.71 | -1.06 | — |
| Basic EPS | -2.95 | -4.34 | -7.71 | -1.06 | — |
| Diluted NI Availto Com Stockholders | -14.76 Cr | -21.73 Cr | -38.62 Cr | -5.33 Cr | — |
| Net Income Common Stockholders | -14.76 Cr | -21.73 Cr | -38.62 Cr | -5.33 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -14.76 Cr | -21.73 Cr | -38.62 Cr | -5.33 Cr | — |
| Net Income Including Noncontrolling Interests | -14.76 Cr | -21.73 Cr | -38.62 Cr | -5.33 Cr | — |
| Net Income Continuous Operations | -14.76 Cr | -21.73 Cr | -38.62 Cr | -5.33 Cr | — |
| Tax Provision | -4.63 Cr | 2.62 Cr | -3.64 Cr | -0.81 Cr | — |
| Pretax Income | -19.38 Cr | -19.11 Cr | -42.27 Cr | -6.14 Cr | — |
| Other Non Operating Income Expenses | 5.01 Cr | 0.10 Cr | 0.86 Cr | 0.01 Cr | — |
| Special Income Charges | -15.67 Cr | -8.77 Cr | -19.22 Cr | -7.77 Cr | — |
| Net Non Operating Interest Income Expense | -2.69 Cr | -1.93 Cr | -4.16 Cr | 0.02 Cr | — |
| Interest Expense Non Operating | 2.69 Cr | 1.93 Cr | 4.15 Cr | 0.02 Cr | — |
| Operating Income | -6.03 Cr | -8.51 Cr | -18.10 Cr | 2.33 Cr | — |
| Operating Expense | 42.29 Cr | 37.62 Cr | 41.19 Cr | 40.46 Cr | — |
| Other Operating Expenses | 23.89 Cr | 20.61 Cr | 11.11 Cr | 11.50 Cr | — |
| Depreciation And Amortization In Income Statement | 12.30 Cr | 10.67 Cr | 13.42 Cr | 14.51 Cr | — |
| Depreciation Income Statement | 12.30 Cr | 10.67 Cr | 11.98 Cr | 14.51 Cr | — |
| Gross Profit | 36.26 Cr | 29.12 Cr | 23.10 Cr | 42.78 Cr | — |
| Cost Of Revenue | 106.19 Cr | 75.22 Cr | 106.47 Cr | 94.34 Cr | — |
| Total Revenue | 142.45 Cr | 104.33 Cr | 129.57 Cr | 137.13 Cr | — |
| Operating Revenue | 142.45 Cr | 104.33 Cr | 129.57 Cr | 137.13 Cr | — |
| Tax Effect Of Unusual Items | -3.74 Cr | -2.63 Cr | -1.66 Cr | -1.02 Cr | — |
| Tax Rate For Calcs | 0.24 | 0.30 | 0.09 | 0.13 | — |
| Normalized EBITDA | 11.28 Cr | 2.27 Cr | -5.47 Cr | 16.16 Cr | — |
| Total Unusual Items | -15.67 Cr | -8.77 Cr | -19.22 Cr | -7.77 Cr | — |
| Total Unusual Items Excluding Goodwill | -15.67 Cr | -8.77 Cr | -19.22 Cr | -7.77 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | -14.76 Cr | -21.73 Cr | -38.62 Cr | -5.33 Cr | — |
| Reconciled Depreciation | 12.30 Cr | 10.67 Cr | 13.42 Cr | 14.51 Cr | — |
| Reconciled Cost Of Revenue | 106.19 Cr | 75.22 Cr | 106.47 Cr | 94.34 Cr | — |
| EBITDA | -4.39 Cr | -6.51 Cr | -24.69 Cr | 8.40 Cr | — |
| EBIT | -16.69 Cr | -17.18 Cr | -38.11 Cr | -6.11 Cr | — |
| Net Interest Income | -2.69 Cr | -1.93 Cr | -4.16 Cr | 0.02 Cr | — |
| Interest Expense | 2.69 Cr | 1.93 Cr | 4.15 Cr | 0.02 Cr | — |
| Normalized Income | -2.83 Cr | -15.59 Cr | -21.05 Cr | 1.41 Cr | — |
| Net Income From Continuing And Discontinued Operation | -14.76 Cr | -21.73 Cr | -38.62 Cr | -5.33 Cr | — |
| Total Expenses | 148.48 Cr | 112.84 Cr | 147.67 Cr | 134.80 Cr | — |
| Diluted Average Shares | 5.00 Cr | 5.01 Cr | 5.01 Cr | 5.03 Cr | — |
| Basic Average Shares | 5.00 Cr | 5.01 Cr | 5.01 Cr | 5.03 Cr | — |
| Interest Income | — | 0.02 Cr | 0.03 Cr | 0.08 Cr | 0.05 Cr |
| Rent Expense Supplemental | — | 0.24 Cr | 0.27 Cr | 0.20 Cr | 0.42 Cr |
| Preferred Stock Dividends | — | 0.00 | 0.00 | — | — |
| Write Off | — | 8.77 Cr | 0.00 | — | 0.00 |
| Total Other Finance Cost | — | 0.02 Cr | 0.04 Cr | 0.04 Cr | 0.39 Cr |
| Interest Income Non Operating | — | 0.02 Cr | 0.03 Cr | 0.08 Cr | 0.05 Cr |
| Selling General And Administration | — | 4.14 Cr | 5.27 Cr | 7.11 Cr | 6.97 Cr |
| Selling And Marketing Expense | — | 0.92 Cr | 1.69 Cr | 2.01 Cr | 2.97 Cr |
| General And Administrative Expense | — | 3.22 Cr | 3.57 Cr | 5.10 Cr | 4.00 Cr |
| Rent And Landing Fees | — | 0.24 Cr | 0.27 Cr | 0.20 Cr | 0.42 Cr |
| Other Special Charges | — | — | 19.22 Cr | 7.77 Cr | 0.01 Cr |
| Restructuring And Mergern Acquisition | — | — | 0.00 | 0.00 | 0.05 Cr |
| Amortization | — | — | 1.44 Cr | — | — |
| Impairment Of Capital Assets | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Lassonde Industries Inc
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.